Our Team
Driving HCMV immunotherapy solutions with expertise and precision.
Core Team
Leadership Visionary
CEO - Founder, Virology Expert
This visionary leader founded Dense Immune to tackle HCMV through innovative immunotherapy. As CEO, they steer strategic planning and spearhead early-stage research, shaping cutting-edge health solutions.
Medical Strategy Lead
Chief Medical Officer, Founder, Medical Expert
This medical strategist co-founded Dense Immune and serves as Chief Medical Officer, overseeing clinical trial applications and early-stage HSCT care strategies with exceptional precision.
Scientific Innovator
Chief Scientific Officer - Founder
This scientific innovator provides critical guidance to Dense Immune, leveraging deep HCMV research expertise to drive virology-focused strategies and development.
Leading researcher
R&D - Founder
This Research leader heads vaccine development efforts, advising Dense Immune on immunotherapy advancements to deliver effective HCMV solutions worldwide.
Advisory Council
Our advisory council includes distinguished specialists in regulatory affairs, technology transfer, and intellectual property, bringing extensive expertise and strategic foresight. Their profound industry knowledge and innovative approaches are pivotal in steering Dense Immune toward pioneering advancements in HCMV immunotherapy, ensuring robust growth and global impact.
Join Our Mission
Partner with Dense Immune to advance HCMV immunotherapy solutions.
Get in Touch